Kolkata, September 7, 2022: The Department of Pharmaceutical Technology of Maulana Abul Kalam Azad University of Technology (MAKAUT), WB is organizing a webinar series on Pharmacovigilance. The topic on 03.09.2022 is Connection with Pharmacovigilance in Times of COVID-19.
One of the eminent speakers is Mr. Saikat Biswas, Global Head- Medical Devices, Pharma, Services, Manufacturing, Energy & Utilities, DOP at Wipro Limited, Kolkata. He has more than 22 years of experience in IT/ KPO/BPO industry, driving strategic global programs for Fortune 500 clients.
Pharmacovigilance deals with drug-related problems: detecting, explaining and preventing adverse effects. Patient safety is the main objective of pharmacovigilance. Many approved drugs carry a risk of adverse reactions. While the benefits to the patient outweigh these risks, physicians and researchers must remain cautious of any serious side effect. The pharmacovigilance monitoring of COVID-19 patients is an international priority. All health authorities and organizations encourage this activity in an attempt to guarantee health transparency and to be allowed to judge the benefit/risk of therapies being attempted or proposed for a specific validated treatment. Due to the spontaneous notification required for this pharmacovigilance activity, and in this particular context of the pandemic, healthcare professionals are overwhelmed by the workload. The specialized authorities are soliciting active and exhaustive data collection from the different services, receiving COVID-19-positive patients, of any suspected adverse effect that may be related to or associated with the use of any drug. This allows the detection, analysis, and evaluation of the tolerance of the drugs prescribed.
Corporate Comm India (CCI Newswire)
